Menu Close

Life Sciences

Investment Strategy / Life Sciences

Life Sciences

Through the study of living organisms, Life Sciences forms the basis for progress in various areas, ranging from biotechnology and agriculture to nutrition and health, etc. As such, companies that carry out research and development in this domain, are closely linked to our daily lives. 

By investing in Life Sciences, Korys strives to have a positive impact on people’s health. We support companies that develop innovative products or offer services that help detect, prevent or cure diseases.

Moreover, Life Sciences are interesting from an economic perspective, as exemplified by the fascinating local ecosystem in Belgium and Europe as a whole. Korys is committed to investing on a long-term basis. Within Life Sciences, we focus primary on the following areas: 

Companies in Life Sciences help detect, prevent or cure diseases.
  • Medical applications
    Diagnostics, devices or therapies which assist in making a rapid and accurate medical diagnosis, or aim to prevent or cure diseases.
  • HealthTech
    HealthTech companies optimise data traffic and data processing. By facilitating research and optimizing diagnostics and/or patient treatment, they aim to improve the health of individuals.
  • Services and tools
    Companies offering services or technologies for pre-clinical or clinical research and development are included in this category. A few examples to clarify:
  • ReMYND supports the pre-clinical development of therapies for neurological diseases (e.g. Alzheimer’s disease, Parkinson’s disease) by offering innovative disease models
  • MRM Technologies and Mimetas work with technologies which simulate the human system, offering the ability to tests new drugs
  • AgTech and FoodTech
    Finally, Korys invests in new technologies which improve food production. We assess the entire value chain, from new forms of biological pest control to innovations which extend the shelf life of produce for the consumer.
Schermafbeelding 2019-05-13 om 11.35.05
Schermafbeelding 2019-05-13 om 11.36.20

Our participations in Life Sciences